Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The tech aims to walk a fine line of not overloading customers with bad ads as several streamers launch their own ad-supported tiers.
In addition to offering mobile headquarters for families on vacation, recreational vehicle sales are a pretty good indicator of the economy.
Peloton reported sales growth of 0.2% in the latest quarter, its first quarter of year-over-year revenue growth since late 2021.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Arch Resources and Consol Energy announced plans for a merger to create a new $5.2 billion coal giant called Core Natural Resources.
Both Target and TJ Maxx posted stellar earnings results on the strength of the incredibly resilient US consumer.
Antitrust regulators in India flagged Disney’s $8.5 billion merger with Reliance for competition concerns in cricket broadcast rights.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
GM is cutting over 1,000 workers, equivalent to roughly 1.3% of its total workforce, from its software and services division.
Functional beverages — drinks producers tout as having health benefits because they have been infused with bioactive compounds.
After nearly 3,000 years, the business of the Olympics is ripe for disruption. Could performance enhancing drugs shake up the games?
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.